Trillium tschonoskii maxim extract attenuates abnormal Tau phosphorylation

Area of Science:

• Neuroscience
• Pharmacology
• Traditional Chinese Medicine

Background:

• Hyperhomocysteinemia is a significant risk factor for Alzheimer's disease (AD).
• Trillium tschonoskii maxim, a traditional Chinese medicine, is used for memory enhancement, but its mechanisms are unclear.
• Understanding the neuroprotective potential of T. tschonoskii maxim against AD-related cognitive deficits is crucial.

Purpose of the Study:

• To investigate the neuroprotective effects of Trillium tschonoskii maxim extract against homocysteine-induced cognitive deficits in a rat model.
• To elucidate the underlying mechanisms involving Tau phosphorylation and hippocampal structure.
• To evaluate the extract's efficacy in improving learning and memory.

Main Methods:

• Alzheimer's disease model induced by homocysteine injection in rats.
• Treatment with Trillium tschonoskii maxim extract via intragastric administration.
• Behavioral tests: Open field test and Morris water maze test.
• Biochemical assays: Western blot for Tau protein and phosphatase activity, immunohistochemistry for Tau, and Golgi staining for dendritic spines.

Main Results:

• Homocysteine induced significant learning and memory deficits, increased Tau phosphorylation, and decreased protein phosphatase 2A activity.
• Homocysteine exposure led to a reduction in hippocampal dendritic spine density.
• Trillium tschonoskii maxim extract treatment effectively reversed these homocysteine-induced pathological changes.

Conclusions:

• Trillium tschonoskii maxim extract demonstrates significant neuroprotective effects against homocysteine-induced cognitive impairment.
• The extract mitigates abnormal Tau phosphorylation and improves hippocampal structural integrity.
• These findings suggest Trillium tschonoskii maxim extract as a potential therapeutic agent for Alzheimer's disease.